Drug Discovery

The Drug Discovery Series covers all aspects of drug discovery and medicinal chemistry and contains over seventy books published since 2010. Providing comprehensive coverage of this important and far-reaching area, the books encourage learning in a range of different topics and provide valuable reference sources for scientists working outside their own areas of expertise. Books feature case studies to bring different aspects of the drug discovery process alive and they detail the fundamental science necessary for understanding through to the most up-to-date discoveries and cutting-edge technologies. Chapters are written and edited by experienced researchers from both industry and academia. This series will be of particular interest to postgraduate students and medicinal chemists and biochemists working in academia or industry.

Series DOI: 10.1039/2041-3211; Print ISSN: 2041-3203; Electronic ISSN: 2041-3203

Editor-in-Chief
David E. Thurston; King's College London, UK

Series Editors
David Fox; Vulpine Science & Learning, UK
Ian Storer; AstraZeneca, UK
Corey Hopkins; University of Nebraska Medical Center, USA
Gina Xiaojing Wang; Genentech, Inc. USA